ImmunityBio
IBRX
IBRX
126 hedge funds and large institutions have $381M invested in ImmunityBio in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 20 closing their positions.
Holders
126
Holders Change
+22
Holders Change %
+21.15%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
38
Reduced
32
Closed
20
Calls
$24M
Puts
$50.7M
Net Calls
-$26.7M
Net Calls Change
-$12.6M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$55.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$60.8M |
3 |
![]()
3
Rafferty Asset Management
New York
|
$12.5M |
4 |
HP
4
Harbourvest Partners
Boston,
Massachusetts
|
$8.24M |
5 |
5
BlackRock
New York
|
$84.4M |